Citadel Advisors
RNA

Citadel Advisors’s PROSENSA HLDGS N V ORD SHS (NLD) RNA Stock Holding History

Citadel Advisors’s Portfolio RNA Stock Details RNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-2,148
Closed -$30.5K – 9004
2014
Q3 		$18K Sell
2,148
-2,196
-51% -$20.8K ﹤0.01% 7541
2014
Q2 		$55K Sell
4,344
-2,175
-33% -$17.7K ﹤0.01% 6694
2014
Q1 		$37K Sell
6,519
-12,419
-66% -$77K ﹤0.01% 6975
2013
Q4 		$88K Buy
18,938
+18,406
+3,460% +$83.9K ﹤0.01% 5714
2013
Q3 		$4K Buy
+532
New +$12.5K ﹤0.01% 6616

Citadel Advisors's RNA Position: Q4 2014 in Review

Citadel Advisors sold out of PROSENSA HLDGS N V ORD SHS (NLD) (RNA) in Q4 2014, closing a stake of 2,148 shares — an estimated $30.5K sold.

Citadel Advisors first reported a position in RNA in Q3 2013 and held it in 5 quarters. The position peaked at $88K in Q4 2013. 47 funds tracked by Wall St. Rank hold RNA as of Q4 2014.

  • Citadel Advisors reported no remaining PROSENSA HLDGS N V ORD SHS (NLD) position as of Q4 2014 after selling out during the quarter.
  • Citadel Advisors sold 2,148 PROSENSA HLDGS N V ORD SHS (NLD) shares in Q4 2014, an estimated $30.5K.
  • Citadel Advisors first reported a position in PROSENSA HLDGS N V ORD SHS (NLD) in Q3 2013 and held it in 5 quarters.
  • Citadel Advisors's PROSENSA HLDGS N V ORD SHS (NLD) position peaked at $88K in Q4 2013.
  • 47 funds tracked by Wall St. Rank held PROSENSA HLDGS N V ORD SHS (NLD) as of Q4 2014.

Based on Citadel Advisors's 13F filing for Q4 2014, filed 17 Feb 2015.